Skip to content

Evolent Health, Inc. EVH Enterprise value

Enterprise value at other companies

CVS Health logo
CVS HealthCVS
$96.84B+4.3%
UnitedHealth Group logo
UnitedHealth GroupUNH
$295.52B-44.2%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
$378.11M+132%
Astrana Health logo
Astrana HealthASTH
$1.95B+22.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$10B+71.5%
Elevance Health logo
Elevance HealthELV
$86.14B-27.8%

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Calculated from Evolent Health, Inc.’s reported figures.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s enterprise value?
Evolent Health, Inc. (EVH) reported enterprise value of $1.1B in Q1 2026.
How has Evolent Health, Inc.'s enterprise value changed year-over-year?
Evolent Health, Inc.'s enterprise value decreased by 36.5% year-over-year, from $1.73B to $1.1B.
What is the long-term trend for Evolent Health, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s enterprise value has grown at a -2.7% compound annual growth rate (CAGR), from $1.47B to $1.28B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.